PHARMAC in NZ has announced
its intention to trial a contestable
fund, for high cost medicines for rare
disorders, which could be seeking
proposals from pharmaceutical
companies by the end of 2014.
Promoting competition among
suppliers could be the key to
improving patients’ access to high
cost medicines for rare disorders,
said chief executive Steffan Crausaz.
“We know competition leads
to lower prices, and that’s an
area where PHARMAC has an
established track record.
“Our activities in promoting
competition enable New Zealand to
achieve some of the lowest prices
for medicines in the world.
The competition model is
intended to enable patients to
get funded access to rare disease
therapies he said.The above article was sent to subscribers in Pharmacy Daily's issue from 10 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Apr 14
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.